As of 2025-11-13, the Relative Valuation of Emergent BioSolutions Inc (EBS) is 31.24 USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.81 USD, the upside of Emergent BioSolutions Inc based on Relative Valuation is 189.0%.
The range of the Relative Valuation is 30.33 - 32.57 USD.
| Range | Selected | |
| Trailing P/E multiples | 15.1x - 15.7x | 15.3x |
| Forward P/E multiples | 14.7x - 15.2x | 14.9x |
| Fair Price | 30.33 - 32.57 | 31.24 |
| Upside | 180.6% - 201.3% | 189.0% |
| Date | P/E |
| 2025-11-12 | 5.22 |
| 2025-11-11 | 5.26 |
| 2025-11-10 | 5.31 |
| 2025-11-07 | 4.91 |
| 2025-11-06 | 4.96 |
| 2025-11-05 | 5.00 |
| 2025-11-04 | 4.88 |
| 2025-11-03 | 5.07 |
| 2025-10-31 | 6.03 |
| 2025-10-30 | 6.21 |
| 2025-10-29 | 4.54 |
| 2025-10-28 | 4.58 |
| 2025-10-27 | 4.68 |
| 2025-10-24 | 4.71 |
| 2025-10-23 | 4.67 |
| 2025-10-22 | 4.56 |
| 2025-10-21 | 4.57 |
| 2025-10-20 | 4.75 |
| 2025-10-17 | 4.43 |
| 2025-10-16 | 4.54 |
| 2025-10-15 | 4.64 |
| 2025-10-14 | 4.39 |
| 2025-10-13 | 4.49 |
| 2025-10-10 | 4.38 |
| 2025-10-09 | 4.85 |
| 2025-10-08 | 4.78 |
| 2025-10-07 | 4.79 |
| 2025-10-06 | 4.42 |
| 2025-10-03 | 4.42 |
| 2025-10-02 | 4.44 |
| 2025-10-01 | 4.44 |
| 2025-09-30 | 4.26 |
| 2025-09-29 | 4.32 |
| 2025-09-26 | 4.31 |
| 2025-09-25 | 4.22 |
| 2025-09-24 | 4.01 |
| 2025-09-23 | 3.95 |
| 2025-09-22 | 3.95 |
| 2025-09-19 | 3.97 |
| 2025-09-18 | 3.84 |
| 2025-09-17 | 3.77 |
| 2025-09-16 | 3.78 |
| 2025-09-15 | 3.87 |
| 2025-09-12 | 3.93 |
| 2025-09-11 | 3.98 |
| 2025-09-10 | 3.85 |
| 2025-09-09 | 3.99 |
| 2025-09-08 | 3.65 |
| 2025-09-05 | 3.66 |
| 2025-09-04 | 3.69 |